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Dynamic TurboFLASH Subtraction 
Technique for Contrast-enhanced MR 
Imaging of the Prostate: Correlation 
with Histopathologic Results
PURPOSE: To assess whether a Tur­
boFLASH (fast low-angle shot) mag­
netic resonance (MR) sequence can 
improve the accuracy of fast spin- 
echo (SE) endorectal coil MR imag­
ing in  the staging and localization of 
prostate cancer.
MATERIALS AND METHODS: In 57 
patients with prostate cancer, MR 
im aging was performed with the fol­
lowing sequences: Tl-weighted SE, 
T2-weighted fast SE, single-section 
gadolinium-enhanced dynamic sub­
tracted TurboFLASH (one image ev­
ery 1.25 or 2.5 seconds), and late- 
phase gadolinium-enhanced Tl- 
weighted SE. Retrospectively, two 
b linded  independent readers graded 
onset and steepest slope of enhance­
m ent and assessed tumor involve­
m ent and capsular penetration. MR 
findings were correlated with histo­
pathologic results.
RESULTS: On TurboFLASH images, 
prostate cancer was characterized by 
early and rapidly accelerating en­
hancement compared with that of 
surrounding tissues. Average sensi­
tivity, specificity, and accuracy for 
detection of tumor involvement for 
the two readers with TurboFLASH 
images were 73.5%, 81.0%, and 77.5%. 
These values with fast SE images 
were 57,5%, 80.5%, and 72.0%. Depic­
tion of capsular penetration and de­
lineation and staging of tumor were 
better when TurboFLASH images 
were included with fast SE images. 
Differences between the two se­
quences, however, were not statisti­
cally significant.
CONCLUSION: Because the Turbo­
FLASH sequence did not statistically 
significantly improve tumor localiza­
tion and staging results, routine use 
is not recommended. The technique 
may be useful for selected patients 
with equivocal evidence of capsular 
penetration.
Magnetic resonance (MR) imag­ing is considered an effective 
tool for staging prostate cancer (1).
The information obtained with this 
modality, however, adds little to the 
information obtained by the tradi­
tional means of clinical staging and 
biopsy, such as tumor grade, number 
and length of cores containing malig­
nancy, and involvement of seminal 
vesicles (2-4).
The use of a gadolinium chelate to in­
crease the diagnostic information of MR 
imaging has been described in the litera­
ture (5-10). The results of these studies 
suggest that contrast material-enhanced 
Tl-weighted MR imaging does not pro­
vide additional information compared 
with that obtained from T2-weighted 
imaging, but that the Tl-weighted se­
quence may be useful in evaluating 
seminal vesicle invasion in equivocal 
cases (6,10). Therefore, the use of a gado­
linium chelate is not warranted for rou­
tine staging of prostate cancer. Brown 
et al (8) evaluated early-phase, Tl- 
weighted, bolus-enhanced MR imaging 
for the evaluation of prostate cancer. 
They found that the information pro­
vided by Tl-weighted images during 
the early phase of contrast enhancement 
enables the best delineation of tumor 
within the gland.
Experience with dynamic subtraction 
TurboFLASH ([fast low-angle shot] Sie­
mens, Erlangen, Germany) MR imaging 
in bladder and breast cancer indicates 
that malignant lesions demonstrate an
earlier and faster enhancement com­
pared with that of benign lesions (11,12). 
To our knowledge, the diagnostic value 
of fast dynamic contrast enhancement in 
prostate cancer has not been evaluated 
previously. The aim of the present study 
was to evaluate the complementary di­
agnostic value of single-section dynamic 
subtraction TurboFLASH MR imaging in 
patients with prostate cancer.
MATERIALS AND METHODS
The patient population comprised 57 
men (age range, 48-73 years; mean age, 64 
years) with clinically localized prostate 
cancer who underwent dynamic subtrac­
tion TurboFLASH MR imaging comple­
mentary to the routine staging MR exami­
nation of the prostate. The examinations 
were performed between August 1993 and 
February 1996. Only patients who under­
went radical prostatectomy were included 
in this study. Patients who received hor­
monal treatment before surgery were ex­
cluded from this study. Biopsy procedures 
preceded MR imaging by an average of 3 
weeks. Patients underwent radical prosta­
tectomy within 3 weeks after imaging. All 
prostatectomy procedures were performed 
in patients in whom no lymph node metasta- 
ses were found at laparoscopic lymph node 
dissection before the operation or at frozen 
section examination during the operation.
MR Technique
All images were obtained with a com­
mercially available 1.5-T MR system (Mag- 
netom SP; Siemens) by using an endorec­
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Figure 1, Case of a 63-year-old m an  w ith  a poorly  differentiated tum or on the left side, (a) Fast SE im age shows a small low-signal-intensity 
area in the peripheral zone on the left side (arrow), (b) Time image show s very  early and  rap id  enhancem ent, (c) Negative slope image shows a 
relatively high w ashout, (d) Postcontrast T l-w eigh ted  image fails to depict the tum or ow ing to its relatively low signal intensity. The matrix 
size (126 X 126) w as chosen erroneously, (e-g) D ynam ic subtracted TurboFLASH images show  early and  rapid  enhancem ent of the tumor. 
There is also some enhancem ent outside the con tour of the prostate  (arrow), This was in terp re ted  as capsular perforation by one reader. Infor­
mation obtained from tim e-signal in tensity  curves show ed th a t this area enhanced  earlier b u t the increase in signal intensity was less than that 
of the tumor, (h) Gross pathologic specim en show s small poorly  differentiated tum or on  the  left side (red); there was no capsular perforation.
tal coil (MRInnervu; Medrad, Pittsburgh, 
Pa). The coil was inserted with the patient 
in the lateral decubitus position and in­
flated with 50-100 cm3 of air. Peristalsis 
was suppressed by means of intravenous 
administration of 1 mg of glucagon. A 
tight band was wrapped around the pa­
tient's abdomen to decrease respiratory 
movement.
First, a sagittal Tl-weighted localizing 
image was obtained to confirm the posi­
tion of the coil and to select locations for 
the axial images. Axial Tl-weighted im­
ages (420/22 [repetition time msec/echo 
time msec], two signals acquired) as well 
as axial, sagittal, and coronal fast spin- 
echo (SE) T2-weighted images (2,940/160/ 
echo train length of 13, three signals ac­
quired) were obtained. All examinations 
were performed with a 4- or 5-mm section 
thickness, a 0.8-1.5-mm gap, a 26-cm field 
of view, and a 512 x 216 matrix. An equal­
izing processing with application of a filter 
algorithm to compensate for near-field 
effect was used. We interchanged the di­
rection of the phase-encoding gradient 
and the read-out gradient to decrease mo­
tion artifacts over the prostate.
The section for the gadolinium-en­
hanced MR images was selected from the 
T2-weighted axial fast SE images. A sec­
tion was chosen in which tumor and nor­
mal prostatic tissue were likely to be pres­
ent. When no tumor was visible, a level 
that demonstrated normal anatomic de­
tails or benign prostatic hyperplasia (BPH) 
was chosen. As the study proceeded, we 
preferably studied a section in which cap­
sular penetration was not obvious. In this 
section during intravenous bolus injection 
of 0.1 mmol of gadopentetate dimeglu- 
mine (Magnevist; Schering, Berlin, Ger­
many) per kilogram of body weight, 63 
images were obtained by using a single­
section TurboFLASH magnetization-pre­
pared sequence (7/3/15 [repetition time 
msec/echo time msec/inversion time 
msec], 10° flip angle, 128 x 256 matrix, 
200-mm field of view, 1-cm section thick­
ness) with a speed of one image per 2.5 
seconds in 15 patients (two signals ac­
quired) and a speed of one image per 1.25 
seconds in the other 42 patients (one sig­
nal acquired). Finally, multisection, axial, 
late-phase, postcontrast Tl-weighted SE 
images (420/22, two signals acquired) 
were obtained. The examinations was per­
formed by using a 4- or 5-mm section 
thickness, a 0.8-1.5-mm gap, a 26-cm field 
of view, and a 512 x 216 matrix.
The dynamic single-section images were 
transferred to a diagnostic workstation 
(Hewlett-Packard, Palo Alto, Calif). In our 
department, a computer program was de­
veloped to subtract the TurboFLASH im­
ages and to calculate color-coded time and 
slope images and maximal signal intensity 
images (Fig 1) (11,12). For the time images, 
the beginning of enhancement of prostatic 
tissue in relation to the beginning of arte­
rial enhancement was color coded and 
projected over the unenhanced image.
The beginning of enhancement was de­
fined as an increase of 10 arbitrary units 
above the base noise line. For the positive 
slope image, the slope of maximal signal
intensity increase was color coded. For the 
negative slope images (washout), the 
slope of signal intensity decrease, after 
maximal signal intensity, was color coded. 
The maximal signal intensity images dis­
play maximal enhancement 45 seconds 
after the beginning of arterial enhance­
ment. Time-signal intensity curves were 
made in operator-defined regions of inter­
est to determine enhancement patterns of 
iliac vessels and benign and malignant 
prostatic tissue, (Note: The subtraction 
technique is commercially available on 
most MR systems. The software program 
for time, slope, and maximal signal inten­
sity images is available from the authors 
on request.)
MR Image Evaluation
The T2-weighted fast SE images, the 
Tl-weighted postcontrast images, and the 
subtracted images were interpreted inde­
pendently by two observers (G.J.J., J.O.B.) 
who were blinded to the clinical findings 
and laboratory and imaging results.
The T2-weighted, postcontrast Tl- 
weighted, and dynamic subtracted Turbo­
FLASH images were interpreted for pres­
ence and location of tumor and capsular 
penetration by tumor. At the level of the 
dynamic subtracted TurboFLASH images, 
the prostate was divided into four areas: 
peripheral zone left and right and central 
zone left and right. The presence of tumor 
was scored on a five-point scale: 1 = defi­
nitely absent, 2 = probably absent, 3 =
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Figure 2. Case of a 63-year-old-man with tumor involvement on the right side, (a) T2- 
weighted fast SE image shows retraction of the capsule on the right side (arrow) that was not 
interpreted as capsular penetration, (b) Dynamic subtracted TurboFLASH image shows en­
hancement outside the contour of the prostate (arrow) interpreted as capsular perforation. 
Capsular perforation was present at final pathologic examination, (c) Histopathologic speci­
men at the level of the right neurovascular bundle shows that, at the dorsolateral side/ tumor 
is present and growing outside the prostatic capsule (pT3a, in which p = pathologic classifica­
tion and a = unilateral capsular extension) (arrows). (Hematoxylin-eosin stain; original mag­
nification, x20.)
indeterminate, 4 = probably present, 5 = 
definitely present. Capsular penetration 
was scored on a three-point scale: 1 ~ no,
2 = indeterminate, 3 = yes. Regions repre­
senting cancer were outlined in a diagram. 
The area of tumor involvement for each 
lesion w as determined by using the ellip­
soid formula, and the total area of cancer 
involvement was calculated as the sum of 
cancer areas on the selected section.
On T2-weighted images, an area in the 
peripheral zone with relatively low signal 
intensity was considered to represent ma­
lignancy. Low-signal-intensity areas in the 
central zone were not interpreted as being 
malignant; however, when an obvious 
malignant peripheral lesion extended into 
the central zone, this was interpreted as 
positive for central tumor involvement. If 
a low-signal-intensity area showed high 
signal intensity on the corresponding Tl- 
weighted image, the area was considered 
to be hematoma. The criteria for capsular 
perforation were disruption of the pros­
tatic capsule, infiltration of the peripros­
tatic fat, low-signal-intensity stranding, 
and involvement of the neurovascular 
bundle. A bulge in the contour or capsular 
thickening was interpreted as "probable" 
(2 on the three-point scale) capsular perfo­
ration (13).
The onset and slope of enhancement 
were assessed on hard-copy images made 
of the subtraction set. The onset of en­
hancement of prostatic tissue in relation to 
the onset of arterial enhancement was reg­
istered in seconds, The slope of enhance­
ment was scored on a three-point scale:
1 ~ slow, 2 = normal, 3 = fast.
On the subtracted images, a lesion was 
considered to represent malignancy if the 
slope of enhancement was faster and the 
onset was earlier relative to the adjacent 
prostatic tissue. Enhancement outside the 
contour of the prostate was considered to 
represent capsular penetration (Fig 2).
With use of these criteria, the additional 
value of the TurboFLASH technique was 
assessed.
Pathologic Examination
The prostatectomy specimens were 
fixed in toto overnight in a solution of 10% 
neutral buffered formalin. Step sections 
were made at 4-mm intervals in a plane 
parallel to the base of the prostate, which 
corresponded to the sections used for axial 
MR imaging. After separating the step sec­
tions into right and left halves, all sections 
were routinely embedded in paraffin. Tis­
sue sections of 4 pirn were prepared and 
stained with hematoxylin-eosin. Regions 
representing cancer were outlined on the 
glass cover and retraced onto a diagram of 
the axial histologic sections that extended 
from the base to the apex of the prostate. 
The area of tumor involvement for each 
lesion was determined by using the ellip­
soid formula, and the total area of cancer 
involvement was calculated as the sum of 
cancer areas on the selected section. Mea­
surements were multiplied by a factor of 1.1 
to correct for tissue shrinkage due to fixation.
Data Analysis
Analysis of the correlation of MR find­
ings and histopathologic results was per­
formed by two radiologists (G J.JV J.O.B.) 
and one pathologist (E.T.G.R). The MR 
images were correlated with tumor maps 
on the basis of the histopathologic sec­
tions, The level of the dynamic subtracted 
TurboFLASH images was determined by 
its location between the apex and base of 
the prostate. The corresponding patho­
logic slice of the tumor map was then ad­
justed, Because of the difference between 
section thickness of the TurboFLASH im­
ages (10 mm) compared with that of the 
fast SE images (4 mm) and the gross speci­
men (4 mm), tumor maps of adjacent 
pathologic slices were also considered.
Penetration through the capsule was 
compared for each quadrant.
Statistical Analysis
The McNemar test (exact distribution) 
was used to evaluate the differences in 
assessing tumor presence and capsular 
penetration with both techniques.
Cohen k  analysis was used to test for 
agreement between both readers with re­
spect to the presence and absence of tu­
mor and capsular penetration: k  < 0.40, 
poor agreement; k  = 0.4-0.75, good agree­
ment; k  > 0.75, strong agreement.
When sensitivity and specificity values 
for tumor presence were calculated, scores 
4 and 5 were considered "present." When 
sensitivity and specificity values for capsu­
lar penetration were calculated, score 3 
was considered "present."
Additional Diagnostic Value
The overall additional diagnostic value 
of dynamic subtracted TurboFLASH im­
ages to routine MR imaging was deter­
mined as follows: Major improvement of 
the diagnostic performance was present 
when dynamic subtracted TurboFLASH im­
ages allowed correct overstaging (T2-»T3) or 
understaging (T3—>T2), minor improvement 
was present when the estimated area of 
tumor involvement as determined on the 
dynamic subtracted TurboFLASH images 
came within the 25% range of the actual 
tumor (Figs 3,4). Diagnostic performance 
was defined as "worse staging" when 
over- or understaging was incorrect with 
dynamic subtracted TurboFLASH images 
and "worse (minor)" when the estimated
Volume 203 • Number 3 Radiology • 647
f * *> :—> U K ;# ,'**< # .> i . V - 7 I r T r ! ^ r ^ s r iT O  ' . t
............. -O s^ '-■ ■i'-vi:;::-.;^ ¿'/>:r;:i:^ -'^ /^r:r»i?i=:>.Li¿-:1
i "  -, •••• •.'•' /  r^i:
:■■ - - ; ■-' -.V .'i.i ^
.1  ' ■' 1 . '  ^ i  ^ '-jl'.J 'f' : ' ' ■" ■ ' ¿^  \ y ;^ '"^ v v | : ^
si.:. ' / ' V s *  . * ■
■: ■; :;;£ftv;. ■ ■
■ ' /■'s/>w:%' > ■. ■ * r•.■■/' '>'A'.i'- :■.■
 ^j : ^  tv.-}: c-: ~. -.^ t:-~i ^ rf.f.'r-^ i-<x>^.v i.i:^ .[^ .if:: -
V- :•
- 1 : • --  : ;  - .
■i-te'X'.-y.v  . r.*•. r>-; >'
a. b.
v.* I / V.v . ^ / . . *  v -  - .*  r  *•:*•*. .V . ’  '  V * - '  s  • . . *  . . V*
a -V ;v ^ r  v: -
•:> . •  w v .':S:• 1 • ✓ ,  r.;*v\  .•;,.</.• : ,. :...:;' ^ l l , j : . • •'  , ; . . ->:, . ('?;.v <•': ’.rv' • Vv iv. . *.. ';• :Y.: /_:. y •> • • • * .•• • V' v - \ .* : .. y +:}’>' ,•'•:)  V . . : *  . ' •  • « ;  V  . < . . : • : • • •  /
y> t'fj’.t,', - ¡ v \ / .  ; •  *: . V  , ' * • • *  * - \  j * s
C.
■mSMi >.i*/./>•', • .* I B K L W : . I A * >
jr>. r J ?•':
ii# 7  # i f e
<*'
mm : - :
•s  •  '  V  ',*Cvi
• *•':.* y i^i* 
*; 7 0 v i
:■ v ^ V - : . ;  -
mmm
d.
4
Figure 3. Case of a 66'year-old man with prostate cancer, (a) 12-weighted fast SE image shows a low-signal-intensity area on the left side and 
bulging of the contour (arrow). This was interpreted as a T2 tumor by one observer and a T3 tumor by the other, (b) Dynamic subtracted Tur­
boFLASH image shows little enhancement, (c) Time image shows late enhancement, and (d) slope image shows slow enhancement. No tumor 
was found at the corresponding level at final pathologic examination.
a.
area of tumor involvement as determined 
on the dynamic subtracted TurboFLASH 
images exceeded the 25% range of the ac­
tual tumor area correlated with the corre­
sponding step-sec tion histologic slice (Fig 
5). Additional information of dynamic sub­
tracted TurboFLASH images that did not 
change the final staging result was called 
"minor/' For example, dynamic subtracted 
TurboFLASH images depicted capsular 
penetration not depicted on fast SE im­
ages, but fast SE images had already de­
picted seminal vesicle invasion (T3c),
RESULTS 
Correlating MR and 
Histopathologic Findings
The correlation between MR images 
and the corresponding histopathologic 
section was difficult in most patients.
The most caudal section of the MR im­
ages was 0.5-1.5 cm more distal than the 
most apical section of the prostatectomy 
specimen, Also; the angle by which the 
sections were cut in both techniques was 
never exactly the same for either tech­
nique (difference, 5°-15c). Further­
more, the shape of the prostate 
changed after surgery and fixation 
compared with the shape of the gland
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Figure 4. Case of a 57-year-old man with prostate cancer, (a) T2- 
weighted fast SE image shows a small area of low signal intensity 
on the left side (arrow), (b) Dynamic subtracted TurboFLASH and 
(c) time images show symmetrically early and rapid enhancement 
of the peripheral zone, (d) Photomicrograph shows moderately 
differentiated tumor. This tumor was present on both sides and 
correlated with the area of enhancement. (Hematoxylin-eosin 
stain; original magnification, x20.)
within the body at the time of imag­
ing. Also making correlation difficult 
was the fact that prostate tumors are 
very irregular and often demonstrate 
fingerlike projections with ill-defined 
margins, which did not display on 
MR images of 4-, 5-, or 10-mm section
thickness (whereas the histologic sec­
tions were only 4 |i,m thick). We tried 
to overcome these problems by using 
tumor maps, which gave a good 
three-dimensional picture of the pros­
tate and were of help in assessing the 
corresponding level.
648 • Radiology June 1997
3. fo> Ct
Figure 5. Case of a 52-year-old man with a very small focus of prostate cancer (0.4 cm3), (a) Time and (b) maximal signal intensity images 
show symmetrically rapid and early enhancement, (c) Gross specimen of the corresponding section shows BPH. No tumor was present at the 
corresponding level.
' 'Table 1
Sensitivity and Specificity for Tumor Localization, with Fast SE and Dynamic 
Subtracted TurboFLASH Imaging
Zone
* Fast SE TurboFLASH
Reader 1 Reader 2 Reader 1 Reader 2
.■ 'v' : ' '
■ ' ' * : Sensitivity
Tum or present
. . - , : \ /
• >
Peripheral [n = 72) 53 (74) 55 (76) 58 (81) 60 (83)
Central (n -  30’ 5(17) 4(13) 17(57) 14(47) •
Total (n «  102) 58 (57) 59 (58) ; 75 (74) 74 (72)
'■ ' > ' \ ; :
t 1 '
Specificity
Tum or absent : : * • * • * • ‘ ( . • ’ :
Peripheral {n —42) 27(64) 22 (52) 24 (57) 31 (74)
Central (n = 84; 82 (98) 81(96) ; 76 (90) 73 (87)
Total (n «  126) ► S' 99 (79) 103 (82) 100 (79) 104 (82)
Note.— Numbers in parentheses are percentages.
Characterization of Enhancement 
Patterns
Differences in enhancement within 
the prostate were best depicted in the 
early phase of the first pass of contrast 
material. However, most glandular 
tissue of the prostate displayed early 
enhancement, and there was a con­
siderable variation between the start 
of enhancement of the external iliac 
artery (t = 0) and the start of en­
hancement of prostatic tissue. There­
fore, the onset of enhancement was 
judged relative to the adjacent pros­
tatic tissue. We were also not able to 
characterize the time-signal intensity 
curve (slope of enhancement) for ma­
lignant or benign lesions. Therefore, 
relative differences in slope values in 
the selected section were used to dif­
ferentiate between benign and malig­
nant lesions.
Interobserver Agreement
Interobserver agreement for the 
interpretation of MR images with and
without the dynamic subtracted Tur­
boFLASH sequence was strong. The 
Cohen k  values were 0.79 and 0.78, 
respectively.
Both observers agreed that nondy­
namic Tl-weighted postcontrast im­
ages did not provide additional infor­
mation compared with T2-weighted 
fast SE images.
Detection of Tumor
A total of 228 quadrants were iden­
tified, rated, and analyzed. Tumor 
was present in 102 quadrants, The 
results for predicting tumor presence 
with and without dynamic subtracted 
TurboFLASH images are presented in 
Table 1. For each reader, the sensitiv­
ity for detection of tumor with fast SE 
images was 57% and 58%, respec­
tively, and with dynamic subtracted 
TurboFLASH images was 74% and 
73%, respectively (the differences be­
tween sequences were not statistically 
significant). The specificity for fast SE 
images was 79% and 82% and for dy­
namic subtracted TurboFLASH im­
ages was 79% and 83%, per reader 
respectively (the differences between 
sequences were not statistically sig­
nificant). The accuracy for fast SE im­
ages was 73% and 71% and for dy­
namic subtracted TurboFLASH 
images was 77% and 78% (the differ­
ences between sequences were not 
statistically significant).
Tumor Volume
In 17 (30%) and 18 (32%) of the 57 
patients, the area of tumor involve­
ment estimated with fast SE images 
was within the 25% range of the ac­
tual area of tumor involvement, per 
reader respectively. With dynamic 
subtracted TurboFLASH images, the 
estimated tumor volume was within 
the 25% range in 23 (40%) and 25 
(44%) patients (the differences be­
tween sequences were not statistically 
significant).
Capsular Penetration
Two hunderd twenty-eight quad­
rants were evaluated. Capsular pen­
etration was present at histopatho­
logic examination in 19 different 
quadrants, in 14 patients. In the re­
maining 209 quadrants, capsular pen­
etration was absent, including one 
site where capsular penetration could 
not be evaluated because the surgeon 
incised the capsule. With fast SE im­
ages, the readers correctly diagnosed 
capsular penetration in four and three 
quadrants, respectively. False-positive 
diagnoses were made at two sites. 
With dynamic subtracted Turbo­
FLASH images, the readers correctly 
diagnosed capsular penetration in 
nine and 10 quadrants, respectively. 
With dynamic subtracted Turbo­
FLASH images, false-positive diag-
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noses were made in one and two 
quadrants, per reader respectively. 
When considering both sequences, 
capsular penetration was predicted 
more accurately with dynamic sub­
tracted TurboFLASH images by both 
readers in six and nine quadrants in 
six (11%) and nine (16%) patients, 
respectively, but less accurately in 
zero and two quadrants in zero and 
two (4%) patients (the differences be­
tween sequences was not statistically 
significant). Three other patients, in 
whom the findings were true-nega- 
tive for capsular penetration, had cap­
sular penetration at a different level 
than that of the dynamic subtracted 
TurboFLASH images. Capsular pen­
etration was depicted in one of these 
three on fast SE images.
Additional Diagnostic Value
The additional diagnostic value of 
dynamic subtracted TurboFLASH im­
ages to routine MR imaging is sum­
marized in Table 2. We achieved over­
all major improvement in five and seven 
patients, per reader respectively, and 
overall minor improvement in eight and 
six patients, respectively.
DISCUSSION
The merit of MR imaging is in the 
local staging of prostate cancer. Al­
though microscopic capsular penetra­
tion may not be demonstrated on T2- 
weighted images, MR imaging may be 
helpful in selecting patients with a 
potentially resectable disease (13,14). 
More accurate staging, however, is 
needed.
Several studies have addressed the 
use of contrast material in MR imag­
ing of the prostate (5-10,15). In the 
normal prostate, the central zone en­
hances more than the peripheral 
zone. Both enhance homogeneously. 
In the presence of BPH, the enhance­
ment pattern of the central gland is 
markedly inhomogeneous (6,8). BPH 
may occasionally arise within the pe­
ripheral zone of the prostate, leading 
to an inhomo gene ous enhancement.
Prostate cancer is frequently re­
ported to show increased enhance­
ment compared with that of adjacent 
glandular tissue, especially in the pe­
ripheral zone; in the central zone, the 
difference is less obvious (8).
Reported studies suggest that con­
trast enhancement in prostate cancer 
is of limited value and may be only 
helpful in cases of seminal vesicle in­
vasion (6,15).
Brown et al (8) evaluated bolus- 
enhanced MR imaging in prostate
carcinoma. They showed that early- 
phase contrast-enhanced images best 
enabled the definition of tumor 
within the gland in 10 (50%) of 20 pa­
tients and demonstrated capsular 
spread more clearly in eight (80%) of 
the 10 patients. In that study, no patho­
logic correlation could be obtained.
Malignant breast, bladder, and 
bone tissues have demonstrated early 
and fast enhancement. The enhance­
ment pattern can be characterized by 
the onset of enhancement (11,16) or 
by the slope of enhancement (17). We 
evaluated the enhancement of pros­
tate cancer during the first pass of 
contrast material with fast dynamic 
imaging with a temporal resolution of 
one image per 1.2 or 2.24 seconds af­
ter bolus administration of intrave­
nous contrast material. Our findings 
indicate that prostate cancer also en­
hances early and that differences in 
enhancement are visible in the early 
phase of the first pass. However, ow- 
ing to a large variation in the onset 
and slope of enhancement among the 
patients in our study and minor dif­
ferences between the onset of en­
hancement of carcinoma and benign 
tissue, which bring about a consider­
able overlap between benign and ma­
lignant lesions in quantitative mea­
sures, we were not able to define a 
cutoff time nor a slope value to differ­
entiate benign from malignant pros­
tatic tissue. Therefore, the onset and 
slope of enhancement were judged 
relative to adjacent prostatic tissue.
Because we used subjective signs, 
independent double reading was per­
formed to test for interobserver vari­
ability. There appeared to be strong 
agreement between both readers for 
the interpretation of both fast SE and 
dynamic subtracted TurboFLASH im­
ages. This is contrary to other studies, 
which have reported high interob­
server variation in estimating tumor 
location, tumor volume, and capsular 
penetration of the prostate (18,19). 
The high agreement of our readers 
may be due to the study design. The 
section of the dynamic subtracted 
TurboFLASH images was chosen in a 
plane that was likely to contain both 
cancer and normal tissue on the T2- 
weighted fast SE image.
Reported data for detection of tu­
mors with MR imaging are, in gen­
eral, poor especially for central gland 
tumors (20,21). The sensitivity for lo­
calization of tumors with dynamic 
subtracted TurboFLASH imaging was 
consistently better than that with fast 
SE images. It was confirmed that tu­
mors located ventrally and centrally 
in histopathologic specimens were
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easily missed on T2-weighted images. 
With dynamic subtracted Turbo­
FLASH imaging, there were 12 and 10 
more true-positive centrally located 
tumors than that with SE imaging but 
also six and eight more false-positive 
tumors.
Tumor volume is a predictor of 
pathologic stage (22). Except for one 
study performed with an external- 
array coil (23), studies performed with 
endorectal coil (13) and body coil MR 
imaging (24-27) reported a poor cor­
relation between MR tumor volume 
and the volume as calculated from the 
pathologic specimen. Mirowitz et al 
(6) who studied postcontrast Tl- 
weighted images also reported poor 
correlation between the estimated 
and calculated volume. Brown et al 
(8) found better correlation during 
the early phase of enhancement, but 
in that study pathologic confirmation 
was not obtained.
When compared with fast SE im­
ages, dynamic subtracted Turbo­
FLASH images enabled better estima­
tion of the area of tumor involvement 
in 10%-12% of the patients. However, 
in only 30%-32% of patients, the area 
of tumor involvement estimated with 
fast SE images was within the 25% 
range of the actual area of tumor in­
volvement. One reason for overesti­
mating tumor volume on dynamic 
subtracted TurboFLASH images was 
rapid enhancement of an area of BPH 
in the central zone (Fig 5). This error 
can be averted when symmetrically 
central enhancement is not consid­
ered as cancer.
In an overview, Schiebler et al (1) 
stated that body coil MR imaging 
gives unsatisfactory results in the de­
tection of capsular penetration. The 
detection of capsular penetration im­
proved with endorectal coil MR imag­
ing (sensitivity, 67%) compared with 
body coil MR imaging (sensitivity, 
44%) in the same patient cohort (28).
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Results of recent studies with endo­
rectal coil MR imaging, however, 
showed a limited accuracy to 33% for 
detection of capsular penetration
(5,13,19,29,30).
In the present study, the sensitivity 
for detection of capsular penetration 
was 21% and 16% with fast SE, and 
47% and  53% with dynamic sub­
tracted TurboFLASH, per reader re­
spectively. These values appeared not 
to be statistically significant. The low 
sensitivity for detection of capsular 
penetration with fast SE is because, 
at least in part, we only studied one 
level, preferably in which capsular 
penetration was not obvious. False- 
positive results on dynamic sub­
tracted TurboFLASH images may be 
due to enhancement of a capsular 
artery. The vessel may be differenti­
ated from tumor by a different en­
hancement curve (Fig 1).
Better prediction of capsular penetra­
tion is of clinical relevance because 
pathologic stage is the most important 
prognostic factor. Staging results im­
proved because of a more accurate as­
sessment of the capsule with dynamic 
subtracted TurboFLASH (Table 2).
T2-weighted MR images do not 
provide information about tumor 
grade, another predictor of clinical 
outcome. A noteworthy finding of the 
present study was that dynamic sub­
tracted TurboFLASH images depicted 
all poorly differentiated tumors and 
that five of them showed the earliest 
and fastest enhancement of all le­
sions. These numbers are, however, 
too small for statistical analysis, and 
our study was not designed to differ­
entiate between low-grade and high- 
grade lesions. These preliminary find­
ings seem to be in contradiction with 
the findings of Yoshizako et al (9), 
who reported that poorly differenti­
ated tumors demonstrate less en­
hancement on contrast-enhanced 
Tl-weighted images than that of 
moderately differentiated tumors. 
However, we also observed that rap­
idly enhancing tumors demonstrated 
relatively low signal intensity on late- 
phase postcontrast images (Fig Id), 
which may be explained by the high 
washout of contrast material from the 
tumor (Fig lc).
Our study shows that the results of 
MR imaging with the dynamic sub­
tracted TurboFLASH sequence were 
consistently better than those of rou­
tine MR imaging, although routine 
use of single-section dynamic sub­
tracted TurboFLASH images did not 
statistically significantly improve tu­
mor localization and staging results. 
The results of dynamic subtracted
TurboFLASH imaging may, however, 
be improved. First, there was a learn­
ing curve. Second, a number of exam­
inations were carried out in patients 
in whom the clinical stage was obvi­
ous from fast SE images. In these 
cases, dynamic subtracted Turbo­
FLASH images did not provide addi­
tional information.
More limitations were inherent to 
the TurboFLASH technique we used; 
the single-section imaging technique 
allows evaluation in only one plane. 
Capsular penetration may be present 
at another level. Better delineation of 
tumor and tumor volume may be­
come possible when with echo-planar 
imaging a dynamic multisection tech­
nique can be performed with a time 
resolution of a minimum of 3 seconds. 
Also, the spatial resolution is consid­
erably less than with fast SE images, 
and the section is twice as thick. An­
other limiting factor of our technique 
was the endorectal coil-dependent 
variation of signal intensity through­
out the prostate gland. Especially, le­
sions located ventrally are difficult to 
recognize because they show rela­
tively less enhancement. In addition, 
the rectum-prostate interface is full of 
enhancement-like artifacts. In our se­
ries, better staging occurred predomi­
nantly at the dorsolateral side. The 
assessment at the dorsal side was dif­
ficult. Easily applicable corrections for 
the coil profile maybe helpful. These 
problems may be overcome with the 
introduction of a combined endorec- 
tal-phased array coil, which will 
provide a more homogeneous signal 
through the prostate, a higher signal-to- 
noise ratio, and a decreased reliance on 
filters. Another limitation of the dynamic 
subtracted TurboFLASH technique is 
that onset and slope of enhancement of 
benign and malignant tissue show some 
overlap; therefore, false-positive and 
false-negative results may occur.
In conclusion, we demonstrated 
that prostate cancer shows early and 
rapid enhancement and that with fast 
imaging and the use of a subtraction 
technique tumor assessment may be 
improved. However, routine use of 
the single-section method did not sta­
tistically significantly improve staging 
results. Further improvement of the 
technique may be achieved by applica­
tion of a multisection sequence, by the 
introduction of a combined endorectal- 
phased array coil, and by correction for 
the sensitivity profile of the endorectal 
coil throughout the prostate gland. ■
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